http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID717463_PMID23122817

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID163318509_AID717463_PMID23122817_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID163339215_AID717463_PMID23122817_VALUE7
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID163335776_AID717463_PMID23122817_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID163321981_AID717463_PMID23122817_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID163335777_AID717463_PMID23122817_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID104234145_AID717463_PMID23122817_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID163325369_AID717463_PMID23122817_VALUE4
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Potentiation of doxorubicin-mediated cytotoxicity against human KBVIN cells assessed as reduction in doxorubicin IC50 at 10 uM after 72 hrs by SRB method relative to control
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID163335776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID163321981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID163318509
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID163335777
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID163339215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID104234145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID163325369
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID717463

Total number of triples: 18.